Literature DB >> 33539249

Predicting postoperative liver cancer death outcomes with machine learning.

Yong Wang1, Chaopeng Ji2,3, Ying Wang1, Muhuo Ji1, Jian-Jun Yang1, Cheng-Mao Zhou1.   

Abstract

OBJECTIVE: To investigate the effect of 5 machine learning algorithms in predicting total hepatocellular carcinoma (HCC) postoperative death outcomes.
METHODS: This study was a secondary analysis. A prognosis model was established using machine learning with python.
RESULTS: The results from the machine learning gbm algorithm showed that the most important factors, ranked from first to fifth, were: preoperative aspartate aminotransferase (GOT), preoperative AFP, preoperative cereal third transaminase (GPT), preoperative total bilirubin, and LC3. Postoperative death model results for liver cancer patients in the test group: of the 5 algorithm models, the highest accuracy rate was that of forest (0.739), followed by the gbm algorithm (0.714); of the 5 algorithms, the AUC values, from high to low, were forest (0.803), GradientBoosting (0.746), gbm (0.724), Logistic (0.660) and DecisionTree (0.578).
CONCLUSION: Machine learning can predict total hepatocellular carcinoma postoperative death outcomes.

Entities:  

Keywords:  AUC; Machine learning; hepatocellular carcinoma; mortality; postoperative

Year:  2021        PMID: 33539249     DOI: 10.1080/03007995.2021.1885361

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  2 in total

1.  Prediction of Early Treatment Response to Initial Conventional Transarterial Chemoembolization Therapy for Hepatocellular Carcinoma by Machine-Learning Model Based on Computed Tomography.

Authors:  Zhi Dong; Yingyu Lin; Fangzeng Lin; Xuyi Luo; Zhi Lin; Yinhong Zhang; Lujie Li; Zi-Ping Li; Shi-Ting Feng; Huasong Cai; Zhenpeng Peng
Journal:  J Hepatocell Carcinoma       Date:  2021-11-30

Review 2.  Machine-Learning-Based Disease Diagnosis: A Comprehensive Review.

Authors:  Md Manjurul Ahsan; Shahana Akter Luna; Zahed Siddique
Journal:  Healthcare (Basel)       Date:  2022-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.